| PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release R Singh, U Manjunatha, HIM Boshoff, YH Ha, P Niyomrattanakit, ... Science 322 (5906), 1392-1395, 2008 | 920 | 2008 |
| Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis K Pethe, P Bifani, J Jang, S Kang, S Park, S Ahn, J Jiricek, J Jung, ... Nature medicine 19 (9), 1157-1160, 2013 | 605 | 2013 |
| A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy K Pethe, PC Sequeira, S Agarwalla, K Rhee, K Kuhen, WY Phong, V Patel, ... Nature communications 1 (1), 57, 2010 | 316 | 2010 |
| Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries J Li, SP Lim, D Beer, V Patel, D Wen, C Tumanut, DC Tully, JA Williams, ... Journal of Biological Chemistry 280 (31), 28766-28774, 2005 | 293 | 2005 |
| Ruthenium olefin metathesis catalysts with modified styrene ethers: influence of steric and electronic effects M Zaja, SJ Connon, AM Dunne, M Rivard, N Buschmann, J Jiricek, ... Tetrahedron 59 (34), 6545-6558, 2003 | 210 | 2003 |
| Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis SPS Rao, SB Lakshminarayana, RR Kondreddi, M Herve, LR Camacho, ... Science translational medicine 5 (214), 214ra168-214ra168, 2013 | 164 | 2013 |
| Structure− activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4-and 5-nitroimidazoles P Kim, L Zhang, UH Manjunatha, R Singh, S Patel, J Jiricek, TH Keller, ... Journal of medicinal chemistry 52 (5), 1317-1328, 2009 | 125 | 2009 |
| Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis M Kurabachew, SHJ Lu, P Krastel, EK Schmitt, BL Suresh, A Goh, ... Journal of antimicrobial chemotherapy 62 (4), 713-719, 2008 | 115 | 2008 |
| Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents RR Kondreddi, J Jiricek, SPS Rao, SB Lakshminarayana, LR Camacho, ... Journal of medicinal chemistry 56 (21), 8849-8859, 2013 | 105 | 2013 |
| Structure− activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure− activity relationships P Kim, S Kang, HI Boshoff, J Jiricek, M Collins, R Singh, UH Manjunatha, ... Journal of medicinal chemistry 52 (5), 1329-1344, 2009 | 105 | 2009 |
| Enantioselective synthesis of (−)-gilbertine via a cationic cascade cyclization J Jiricek, S Blechert Journal of the American Chemical Society 126 (11), 3534-3538, 2004 | 93 | 2004 |
| Design, synthesis and biological evaluation of aryl-substituted sialyl Lewis X mimetics prepared via cross-metathesis of C-fucopeptides CM Huwe, TJ Woltering, J Jiricek, G Weitz-Schmidt, CH Wong Bioorganic & medicinal chemistry 7 (5), 773-788, 1999 | 80 | 1999 |
| Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selective proteasome inhibitor for the treatment of leishmaniases A Nagle, A Biggart, C Be, H Srinivas, A Hein, D Caridha, RJ Sciotti, ... Journal of Medicinal Chemistry 63 (19), 10773-10781, 2020 | 67 | 2020 |
| Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents F Yokokawa, G Wang, WL Chan, SH Ang, J Wong, I Ma, SPS Rao, ... ACS Medicinal Chemistry Letters 4 (5), 451-455, 2013 | 54 | 2013 |
| Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors M Saldivia, E Fang, X Ma, E Myburgh, JBT Carnielli, C Bower-Lepts, ... Nature microbiology 5 (10), 1207-1216, 2020 | 49 | 2020 |
| Structure–Activity Relationships of Antitubercular Nitroimidazoles. 3. Exploration of the Linker and Lipophilic Tail of ((S)-2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3 … J Cherian, I Choi, A Nayyar, UH Manjunatha, T Mukherjee, YS Lee, ... Journal of medicinal chemistry 54 (16), 5639-5659, 2011 | 44 | 2011 |
| Lanthanide triple helical complexes with a chiral ligand derived from 2, 6-pyridinedicarboxylic acid G Muller, B Schmidt, J Jiricek, G Hopfgartner, JP Riehl, JCG Bünzli, ... Journal of the Chemical Society, Dalton Transactions, 2655-2662, 2001 | 42 | 2001 |
| Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosis SB Lakshminarayana, HIM Boshoff, J Cherian, S Ravindran, A Goh, ... PloS one 9 (8), e105222, 2014 | 26 | 2014 |
| Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections SPS Rao, MK Gould, J Noeske, M Saldivia, RS Jumani, PS Ng, O René, ... Science 380 (6652), 1349-1356, 2023 | 12 | 2023 |
| Anti-trypanosomal proteasome inhibitors cure hemolymphatic and meningoencephalic murine infection models of African trypanosomiasis SPS Rao, SB Lakshminarayana, J Jiricek, M Kaiser, R Ritchie, E Myburgh, ... Tropical medicine and infectious disease 5 (1), 28, 2020 | 12 | 2020 |
